<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/stylesheet.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link rel="self" type="application/atom+xml" href="https://feeds.transistor.fm/the-glp-1-revolution" title="MP3 Audio"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <podcast:podping usesPodping="true"/>
    <title>The  GLP-1 Revolution</title>
    <generator>Transistor (https://transistor.fm)</generator>
    <itunes:new-feed-url>https://feeds.transistor.fm/the-glp-1-revolution</itunes:new-feed-url>
    <description>In this podcast we share key insights from our self-funded piece of work to explore usage of weight loss jabs, and how this is impacting consumer behaviour. We unpack the meteoric rise of weight loss jabs (GLP-1) and how they’re transforming the way people eat, drink and shop. With over 2.5 million adults already using them, this trend is reshaping consumer behaviour and the affects have potentially far-reaching implications for brands, retailers and food service providers. Tune in to catch the key insights and future implications. </description>
    <copyright>© 2025 Flume Group. Produced by 11c Media</copyright>
    <podcast:guid>d91d80f7-795a-516d-8b54-d3b48249aaac</podcast:guid>
    <podcast:locked owner="podcasts@11c.media">no</podcast:locked>
    <language>en</language>
    <pubDate>Wed, 05 Nov 2025 17:27:11 +0000</pubDate>
    <lastBuildDate>Wed, 03 Dec 2025 08:03:17 +0000</lastBuildDate>
    <link>https://www.flume.group/</link>
    <image>
      <url>https://img.transistor.fm/nywgjoaB4svpNNgrIfP_0DTYpZZ__ljiQkVXz5VU5-c/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NTEz/N2FjYzJkMTg3NGQ3/MGY0MjFlN2M0Mjll/Njg0My5wbmc.jpg</url>
      <title>The  GLP-1 Revolution</title>
      <link>https://www.flume.group/</link>
    </image>
    <itunes:category text="Business">
      <itunes:category text="Marketing"/>
    </itunes:category>
    <itunes:category text="Science">
      <itunes:category text="Social Sciences"/>
    </itunes:category>
    <itunes:type>episodic</itunes:type>
    <itunes:author>Flume Group</itunes:author>
    <itunes:image href="https://img.transistor.fm/nywgjoaB4svpNNgrIfP_0DTYpZZ__ljiQkVXz5VU5-c/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NTEz/N2FjYzJkMTg3NGQ3/MGY0MjFlN2M0Mjll/Njg0My5wbmc.jpg"/>
    <itunes:summary>In this podcast we share key insights from our self-funded piece of work to explore usage of weight loss jabs, and how this is impacting consumer behaviour. We unpack the meteoric rise of weight loss jabs (GLP-1) and how they’re transforming the way people eat, drink and shop. With over 2.5 million adults already using them, this trend is reshaping consumer behaviour and the affects have potentially far-reaching implications for brands, retailers and food service providers. Tune in to catch the key insights and future implications. </itunes:summary>
    <itunes:subtitle>In this podcast we share key insights from our self-funded piece of work to explore usage of weight loss jabs, and how this is impacting consumer behaviour.</itunes:subtitle>
    <itunes:keywords>GLP-1, weight-loss drugs, semaglutide, tirzepatide, Ozempic, Wegovy, Zepbound, consumer behaviour, consumer trends, retail, food service, marketing, brand strategy, shopper insights, nutrition trends</itunes:keywords>
    <itunes:owner>
      <itunes:name>Flume Group</itunes:name>
    </itunes:owner>
    <itunes:complete>No</itunes:complete>
    <itunes:explicit>No</itunes:explicit>
    <item>
      <title>Weight Loss Jabs</title>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>Weight Loss Jabs</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7a2a0222-a6e8-4ad1-b9ea-a6e1cc69b043</guid>
      <link>https://share.transistor.fm/s/95095606</link>
      <description>
        <![CDATA[<p>In this podcast we share key insights from our self-funded piece of work to explore usage of weight loss jabs, and how this is impacting consumer behaviour. We unpack the meteoric rise of weight loss jabs (GLP-1) and how they’re transforming the way people eat, drink and shop. With over 2.5 million adults already using them, this trend is reshaping consumer behaviour and the affects have potentially far-reaching implications for brands, retailers and food service providers. Tune in to catch the key insights and future implications. Got any thoughts or questions? Get in touch at hello@flume.group</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In this podcast we share key insights from our self-funded piece of work to explore usage of weight loss jabs, and how this is impacting consumer behaviour. We unpack the meteoric rise of weight loss jabs (GLP-1) and how they’re transforming the way people eat, drink and shop. With over 2.5 million adults already using them, this trend is reshaping consumer behaviour and the affects have potentially far-reaching implications for brands, retailers and food service providers. Tune in to catch the key insights and future implications. Got any thoughts or questions? Get in touch at hello@flume.group</p>]]>
      </content:encoded>
      <pubDate>Mon, 27 Oct 2025 13:04:06 +0000</pubDate>
      <author>Flume Group</author>
      <enclosure url="https://media.transistor.fm/95095606/13a9d6b9.mp3" length="41350874" type="audio/mpeg"/>
      <itunes:author>Flume Group</itunes:author>
      <itunes:duration>1721</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In this podcast we share key insights from our self-funded piece of work to explore usage of weight loss jabs, and how this is impacting consumer behaviour. We unpack the meteoric rise of weight loss jabs (GLP-1) and how they’re transforming the way people eat, drink and shop. With over 2.5 million adults already using them, this trend is reshaping consumer behaviour and the affects have potentially far-reaching implications for brands, retailers and food service providers. Tune in to catch the key insights and future implications. Got any thoughts or questions? Get in touch at hello@flume.group</p>]]>
      </itunes:summary>
      <itunes:keywords>GLP-1, weight-loss drugs, semaglutide, tirzepatide, Ozempic, Wegovy, Zepbound, consumer behaviour, consumer trends, retail, food service, marketing, brand strategy, shopper insights, nutrition trends</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
  </channel>
</rss>
